Implementing robotic-assisted therapy in stroke rehabilitation: a structured narrative review of evidence and technology adoption barriers in Indonesia.
- 1Department of Physiotherapy, Faculty of Health Science and Technology, Binawan University, Jakarta, Indonesia.
- 2Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
- 3School of Medicine, College of Medicine, Tzu Chi University, Hualien, Taiwan.
Abstract
Introduction
Robotic-assisted therapy (RAT) has emerged as a promising intervention for post-stroke recovery; however, its implementation in developing countries such as Indonesia remains limited by economic, technical, and systemic barriers. This structured narrative review summarizes clinical effect reported by systematics review and meta-analyses and examines implementation consideration and potential economic feasibility within the Indonesian healthcare context.Method
A structured review of systematic reviews and meta-analyses (2015-2025) was conducted using PubMed, Scopus, PEDro, and Cochrane Library. Studies involving adult with stroke were included. Findings were synthesized narratively because of heterogeneity. Implementation barriers were analyzed, and a scenario-based economic model was developed to assess feasibility of RAT in Indonesia. QALY-equivalent outcomes (QEOs) were estimated using ratio-based value-transfer approach that scaled published reference values according to observed functional effects.Result
Evidence from 22 systematic reviews indicated that RAT improved functional outcomes compared with conventional therapy, particularly gait and upper-limb function (effect sizes: 0.02-0.52). Key implementation barriers included limited device availability, inadequate workforce training, and regulatory constraints. Modelled ICERs ranged from US$236.23-752.31 per QEO for upper-limb rehabilitation and US558.86−4,890 per QEO for gait−related rehabilitation. Most estimates remained below the Indonesian willingness−to−pay threshold (<US5,030), suggesting a favourable economic profile under model assumptions, particularly in higher-resource provinces, while lower-income regions may face affordability constraints.Conclusion
RAT shows potential clinical benefits, but implementation in Indonesia should consider clinical effectiveness, economic feasibility, infrastructure, workforce, technology acceptance, and reimbursement. A phased approach in suitable tertiary-care settings may support wider adoption based on local evidence.
Related
- Perspectives on implementing nerve and tendon transfer surgery in spinal cord injury rehabilitation in the USA and Canada: a qualitative study.
- Integrating Wearable Sensor Technology into Outpatient Rehabilitation Care: A Proof-of-Concept Study
- A feasibility study to empower patients with individualised physical rehabilitation through wearable technology: The potential of the ‘RehabBuddy’ system
- Changes in Post-Transplant Vaccine Coverage After Implementing Structured Vaccine Reviews in Pediatric Solid Organ Transplant Recipients in British Columbia, Canada: A Canadian Immunization Research Network Study.
- Implementing high intensity home-based rehabilitation for patients following stroke: a mixed methods study.
BibTeX
@article{wijaya2026implementing,
title = {{Implementing robotic-assisted therapy in stroke rehabilitation: a structured narrative review of evidence and technology adoption barriers in Indonesia.}},
author = {Ezra B Wijaya and Phyo-Wai Thu and Pao-Chu Chen},
journal = {Frontiers in rehabilitation sciences},
year = {2026},
month = oct,
doi = {10.3389/fresc.2026.1942904},
url = {https://europepmc.org/article/MED/42923584},
note = {CC BY},
}
RIS
TY - JOUR
TI - Implementing robotic-assisted therapy in stroke rehabilitation: a structured narrative review of evidence and technology adoption barriers in Indonesia.
AU - Ezra B Wijaya
AU - Phyo-Wai Thu
AU - Pao-Chu Chen
PY - 2026
DA - 2026/10/08
JO - Frontiers in rehabilitation sciences
DO - 10.3389/fresc.2026.1942904
UR - https://europepmc.org/article/MED/42923584
AB - Introduction Robotic-assisted therapy (RAT) has emerged as a promising intervention for post-stroke recovery; however, its implementation in developing countries such as Indonesia remains limited by economic, technical, and systemic barriers. This structured narrative review summarizes clinical effect reported by systematics review and meta-analyses and examines implementation consideration and potential economic feasibility within the Indonesian healthcare context.Method A structured review of systematic reviews and meta-analyses (2015-2025) was conducted using PubMed, Scopus, PEDro, and Cochrane Library. Studies involving adult with stroke were included. Findings were synthesized narratively because of heterogeneity. Implementation barriers were analyzed, and a scenario-based economic model was developed to assess feasibility of RAT in Indonesia. QALY-equivalent outcomes (QEOs) were estimated using ratio-based value-transfer approach that scaled published reference values according to observed functional effects.Result Evidence from 22 systematic reviews indicated that RAT improved functional outcomes compared with conventional therapy, particularly gait and upper-limb function (effect sizes: 0.02-0.52). Key implementation barriers included limited device availability, inadequate workforce training, and regulatory constraints. Modelled ICERs ranged from US$236.23-752.31 per QEO for upper-limb rehabilitation and US558.86−4,890 per QEO for gait−related rehabilitation. Most estimates remained below the Indonesian willingness−to−pay threshold (<US5,030), suggesting a favourable economic profile under model assumptions, particularly in higher-resource provinces, while lower-income regions may face affordability constraints.Conclusion RAT shows potential clinical benefits, but implementation in Indonesia should consider clinical effectiveness, economic feasibility, infrastructure, workforce, technology acceptance, and reimbursement. A phased approach in suitable tertiary-care settings may support wider adoption based on local evidence.
SN - 2673-6861
ER -